Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,471
Recruiting: 1,282
Ph III recruiting: 129
Growth YoY: +2.6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,643)

clinicaltrialsPublishedShowing 551–600 of 2,924 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07608731	Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas	not yet recruiting	Phase 1	18	Allison WinterOTHER	1	Aug 21, 2026	clinicaltrials
NCT07615270	A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement	not yet recruiting	Early Phase 1	5	Stanford UniversityOTHER	1	Aug 21, 2026	clinicaltrials